Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Pfizer stock shows strong potential with updates on danuglipron, robust cost controls, and attractive valuations. Learn more ...

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they ...

Tuesday was a relatively uneventful news day for Pfizer, especially following the pharmaceutical giant's disclosure on Monday ...

Pfizer will end development of weight-loss pill over fears about its impact to the liver - The drugmaker said the patient’s ...

Pfizer has announced that it is discontinuing ... We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

To watch more expert insights and analysis ... Pfizer, as it competes with the likes of Novo Nordisk and Eli Lilly in the weight loss drug space. 00:43 Speaker B Plus, Nvidia announcing a big ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Pfizer PFE underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on ...